Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indonesia Energy Corporation Limited (INDO) vs TransMedics Group Inc (TMDX) Price & Performance

Indonesia Energy Corporation LimitedTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Indonesia Energy Corporation Limited vs TransMedics Group Inc — how do they compare? Indonesia Energy Corporation Limited trades at $2.97 (market cap $45.55M), while TransMedics Group Inc trades at $87.38 (market cap $3.10B). The key difference: TransMedics Group Inc is far larger — about 68.1× Indonesia Energy Corporation Limited's market cap, and TransMedics Group Inc is trading nearer its 52-week high, Indonesia Energy Corporation Limited nearer its low. Which is the better fit depends on your goals.

INDOTMDX
Market Cap
$45.55M$3.10B
Sector
EnergyTechnology
52-Week High
$6.74$150.42
52-Week Low
$2.49$61.99
Enterprise Value
$40.92M$3.49B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indonesia Energy Corporation Limited

INDO trades at $2.97, up 1.71% today, with a bullish technical signal supported by moving averages. The company reported a net loss of $5 million on $2 million revenue in 2025, resulting in negative profit margins. Recent news highlights operational progress with the commencement of drilling at the K-29 well in Indonesia. Analyst consensus is unanimously bullish with three buy ratings.

The outlook hinges on successful well development driving future revenue growth, but high valuation multiples and persistent losses pose significant risks. Investors face volatility from execution challenges in oil and gas exploration, though positive analyst sentiment suggests potential upside if operational milestones are met.

TransMedics Group Inc

TransMedics Group (TMDX) trades at $87.42, down 1.12% on the day, with a bullish technical outlook from moving averages but bearish oscillators signaling potential overbought conditions. The company reported mixed Q2 2026 results, missing earnings estimates with EPS of $0.44 versus $0.50 expected, while revenue growth remains robust. Recent news highlights an ongoing investigation into fiduciary duties by directors, adding uncertainty.

The stock presents a cautious opportunity with strong analyst support (69% buy ratings) and a consensus price target of $99.57, implying upside, but risks include earnings volatility, margin pressures, and legal scrutiny. Fundamentals show solid profitability with a 22.69% net margin, though valuation multiples like P/E of 23.15 suggest premium pricing relative to historical norms.

Returns comparison

Trailing returns across standard periods

About Indonesia Energy Corporation Limited

Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.

Read more on INDO

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX